Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:23 PM
Ignite Modification Date:
2025-12-24 @ 10:23 PM
NCT ID:
NCT00704535
Eligibility Criteria:
Inclusion Criteria:
* Outpatient men or women, age 18 years and above.
* Patients with primary (heterozygous familial and non-familial) hypercholesterolemia or homozygous familial hypercholesterolemia.
Exclusion Criteria:
* Known hypersensitivity to Ezetimibe.
* Moderate to severe hepatic insufficiency.
* Persistent elevation of serum transaminase levels of more than 1.5 times the upper limit of normal.
* Pregnancy or lactation.
* Concomitant intake of bile acid sequestrants (resins), nicotinic acid (niacin), fibric acid (fibrates), or cyclosporine
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00704535
Study Brief:
Protocol Section:
NCT00704535